8-K: PURE Bioscience Reports Strong Q1 Sales Growth, Reduced Loss

PURE Bioscience, Inc. announced fiscal first quarter 2026 financial results, reporting increased net product sales and a reduced net loss.

Summary

• Net product sales for the fiscal first quarter ended October 31, 2025, increased by $152,000 to $707,000, up from $555,000 in the prior year.
• The net loss for the quarter was $464,000, a significant improvement compared to a net loss of $689,000 in the fiscal first quarter ended October 31, 2024.
• Net loss per share improved to ($0.00) for the current quarter, from ($0.01) in the same period last year.
• Gross profit rose to $450,000 from $325,000 year-over-year.
• The company reported continued momentum in key markets, including significant expansion in the produce industry with its PURE Control solution.
• Growth was also noted in the transportation industry, leveraging new SDC-powered sanitation technology with major trucking fleets.
• Cash and cash equivalents increased to $434,000 at October 31, 2025, from $334,000 at July 31, 2025.
• Total current liabilities significantly increased to $3,159,000 at October 31, 2025, from $938,000 at July 31, 2025, primarily due to current convertible notes payable to related parties totaling $2,104,000.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to significant sales growth and a substantial reduction in net loss, indicating operational improvements. However, the company remains unprofitable, has an increasing stockholders' deficiency, and relies on related-party debt, which introduces financial risk and tempers overall optimism.

Positives

• Net product sales increased by 27.4% to $707,000, indicating strong customer adoption and distribution network performance.
• Net loss decreased by 32.7% to $464,000, demonstrating improved operational efficiency and financial management.
• Gross profit increased by 38.5% to $450,000, reflecting better margins or sales mix.
• Selling, general and administrative expenses decreased to $743,000 from $881,000, showing cost control.
• Net cash used in operating activities improved significantly, reducing from $(503,000) to $(250,000).
• Successful expansion of PURE Control in the produce industry, now actively used for leafy greens, marks an important milestone in market adoption.
• Growth in the transportation industry through new SDC-powered sanitation technology and distribution partners.

Negatives

• The company continues to operate at a net loss of $464,000.
• Total stockholders' deficiency increased to $(5,546,000) from $(5,116,000) at July 31, 2025.
• Current convertible notes payable to related parties surged to $2,104,000, contributing to a substantial increase in total current liabilities.
• Interest expense, net, increased to $(94,000) from $(62,000), indicating higher borrowing costs or debt levels.
• Research and development expenses increased to $86,000 from $71,000, which could impact short-term profitability.

Risks

• Failure to implement or achieve the benefits of proposed business initiatives and plans.
• Challenges in achieving market acceptance of current and future products and services, including converting evaluations into customer orders and expanding product use.
• Inability to maintain relationships with partners and other counterparties.
• Difficulty in generating sufficient revenues and reducing operating expenses to achieve profitability.
• Inability to raise the necessary funding to support continued operations and implement the business plan.
• Challenges in developing effective new products and obtaining required regulatory approvals for SDC-based technology.
• Competitive factors, particularly customer acceptance of SDC-based products which are typically more expensive than existing treatment chemicals.
• Dependence upon third-party vendors for product manufacturing.

Future Outlook

The company anticipates continued growth in its core produce business and is actively working with distribution partners to roll out new membrane treatment solutions in the beverage and dairy industry. Management expects to build on the progress made with direct customers and the distribution network.

Management Comments

• "Our fiscal first quarter year-over-year sales growth shows the progress we have made with our direct customers and distribution network."
• "We are continuing to grow our core produce business."
• "At the same time, we are working closely with our distribution partners in the beverage and dairy industry to roll out our new membrane treatment solutions."

Industry Context

PURE Bioscience operates in the antimicrobial and sanitation solutions market, primarily targeting the food and beverage industry, and expanding into transportation. The reported growth in produce and transportation aligns with increasing industry demand for enhanced hygiene and food safety solutions, driven by regulatory pressures and consumer awareness. The focus on non-toxic SDC antimicrobial technology positions the company within a growing segment seeking safer alternatives to traditional chemicals.

Comparison to Industry Standards

• NA

Related Party Transactions

• Convertible notes payable to related parties, current: $2,104,000 as of October 31, 2025.
• Convertible notes payable to related parties, non-current: $3,573,000 as of October 31, 2025.
• Net proceeds from note payable to related parties: $350,000 for the three months ended October 31, 2025.

Stakeholder Impact

• Shareholders: Positive sales growth and reduced losses could signal improving fundamentals, but increased current liabilities from related-party debt and ongoing losses pose risks to equity value and potential for future dilution if further capital raises are needed.
• Customers: Benefit from expanded product availability (PURE Control for leafy greens) and new sanitation technologies (transportation industry), enhancing food safety and hygiene.
• Creditors (Related Parties): Continue to provide financing, indicating ongoing support but also increased exposure to the company's financial performance and ability to repay debt.

Next Steps

• Continue to grow the core produce business.
• Work closely with distribution partners in the beverage and dairy industry to roll out new membrane treatment solutions.

Key Dates

Keywords

Antimicrobial, SDC, Silver Dihydrogen Citrate, Food Safety, Sanitation, Produce Industry, Transportation Industry, Financial Results, Net Sales, Net Loss, Biotechnology, Chemical Safety